Our data underline the need for the early recognition and investigation for gigantism or acromegaly in patients with NF1, including a careful and thorough investigation of the pituitary gland through imaging using techniques for three dimensional volumetric measurements [54], and serial overnight GH and prolactin measurements, if feasible. This evidence concerns the gene PRL and acromegaly.